BRIEF-Zynerba Pharma Q1 loss per share $0.49
May 12, 2016 at 07:15 AM EDT
* Expects that existing cash and cash equivalents will fund its research and development programs and operations through 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|